This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paul D. Hoeprich, MD; Ruth M. Lawrence, MD; Elliot Goldstein, MD

JAMA. 1980;243(19):1923-1926.

Abstract
Miconazole was injected intravenously in six patients with coccidioidomycosis. Two patients received 101 and 185 g, respectively, without clinical response and with persistence of positive cultures for Coccidioides immitis. In one patient, symptoms were suppressed when amphotericin B was given with miconazole, but new lesions developed with miconazole alone (total dose, 963 g). Three patients received smaller doses: 30.6 g before death from an unrelated complication; 17 and 22.3 g before development of severe allergic reactions. Because of the high rate of initial failures and relapses, miconazole is not recommended as primary therapy for coccidioidomycosis.

(JAMA 243:1923-1926, 1980)

Author Affiliations
From the Section of Infectious and Immunologic Diseases, Department of Internal Medicine, School of Medicine, University of California, Davis. Dr Lawrence is now with the Department of Internal Medicine, Texas Tech University School of Medicine, Lubbock.

Footnotes
Reprint requests to 4301 X St, Sacramento, CA 95817 (Dr Hoeprich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?